DIA 48th Annual Meeting
Click here to go to the previous page
Emerging Development and Policy Trends in the Economics of the Biopharmaceutical Industry
Track
:
Track 10: Public Policy/Health Care Compliance/Regulatory Law
Program Code:
362
Date:
Wednesday, June 27, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Joseph DiMasi, Tufts Center for the Study of Drug Development, Tufts University, United States
PRESENTER
(S):
Kathleen Basmadjian
Joseph DiMasi, Tufts Center for the Study of Drug Development, Tufts University, United States Raymond Starrett, Targacept Inc., United States
Description
The implications of industry practices and public policies for R&D productivity and the incentives to innovate will be examined.
Learning Objectives:
Describe drug development metrics that impact industry economics
Analyze emerging industry R&D and market trends and current and proposed public policies that affect incentives to develop new drugs.
Learning Objectives:
Describe drug development metrics that impact industry economics
Analyze emerging industry R&D and market trends and current and proposed public policies that affect incentives to develop new drugs.
This session is a part of:
Handout Online
